Prempro Lawsuit Settles on Eve of Trial

Wyeth, the biggest U.S. maker of birth-control pills, settled on the eve of trial a lawsuit by a terminally ill woman who blamed the company's Prempro menopause drug for her breast cancer.

Cases of Jaw Bone Death Caused by Fosamax often Unreported

According to the American Association of Oral and Maxillofacial Surgeons, there may be "serious underreporting" of Bisphosphonate-Related Osteonecrosis of the Jaw from Merck, the manufacturer of Fosamax.

Wyeth faces first NJ Prempro Trial

Madison-based drugmaker Wyeth faces its first New Jersey Prempro trial today, according to a report on Pharmalot.com.

Questions remain about safety of Hormone Therapy

The picture is getting clearer about hormone therapy, but five years after a landmark study of the treatment was halted many questions are still unanswered.

Wyeth settles 1st NJ Prempro Case

Shortly before the trial was set to begin this morning, the drugmaker Wyeth agreed to end the Deutsch case by making an undisclosed payment.

Boston Scientific settles defibrillator claims for $195M

Boston Scientific Corp. will pay $195 million to settle a class-action suit against its Guidant division, ending a legal battle in which patients claimed Guidant Corp. knowingly hid defects in its implantable heart devices.

Hormone Therapy not for Older Women

If started long after menopause, hormone therapy carries serious risks for older women, a study from the U.K., Australia, and New Zealand shows.

Drug Safety Spending to be Increased

Congress is moving to give federal health officials more money to monitor prescription drug safety, part of an effort to avoid another Vioxx debacle.

What Might that Little Pill Do

Patricia Slingo takes a handful of pills to keep her heart functioning, and when she looks in the mirror, the first thing she sees is a big pink scar on her breastbone, the result of bypass surgery.

Vioxx Warnings Don't Absolve Merck

The Food and Drug Administration's approval of warnings on a drug label doesn't clear the manufacturer of claims that the warnings were inadequate.